An observational study in Coronavirus Infection, sponsored by Cordio Medical. Completed at 1 site in Israel. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-12-12.
Sponsored by Cordio Medical · Observational
Among 18 studies in Coronavirus Infections with a site in Israel — 1 open to participants now, 2 under way, 1 of them phase 3. Coronavirus Infections · Israel.
Among the 18 studies in Coronavirus Infections with a site in Israel, this one is one of 11 that started in 2020, is one of 6 observational ones, and was the 2nd registered.
1,112 studies on the registry are indexed under Coronavirus Infections; 52 are open to participants now.
This study's enrollment of 42 is below the median of 308 across 387 observational studies indexed under Coronavirus Infections.
Browse Coronavirus Infections studies →1 of the 18 studies in Coronavirus Infections with a site in Israel is open now, in 12 countries. Each count lists the studies.
Of the 40 Coronavirus Infections studies recruiting now, 24 (60%) set no upper age limit and 9 (23%) stop at 75 or younger; 13 take children under 18; 20 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →18 studies; the count open now beside each. This study's row is marked.
First in 2020; this study’s year is marked. 11 started in 2020.
Median enrollment 215 across the 12 interventional studies, 518 across the 6 observational. Of the 13 that completed or were terminated, 4 (31%) have results posted.
11 of 18 have an industry lead sponsor. The 10 most frequent:
Cordio Medical is the lead sponsor of 6 studies on the registry; none are open to participants now.
Cordio Medical has 1 study filed under Coronavirus Infections — fewer than ten, so there is no comparison to draw.
1 of the studies in Coronavirus Infections with a site in Israel that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05624450Phase 3AstraZenecaEfficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen | 2027-11-04 |
Among the 18 studies in Coronavirus Infections with a site in Israel, from their registry updates:
Nothing recorded among them since 2026-09-25.
Study on adult patients positive to COVID-19 virus. After signing informed consent and undergoing screening assessments, eligible patients will record few times a day several pre-defined sentences to the Cordio App installed in a smartphone/tablet.
The app will upload the vocal data to the sponsor's servers for analysis. The patient will record at hospital admittance (COVID-19 positive) until patient defined as COVID-19 negative and free of relevant clinical symptoms.
COVID-19 positive patients, from medical center departments, ER, home/hotels hospitalization
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Adult patients positive to COVID-19 virus will record several predefined sentences via a smartphone / tablet and will answer questions via the app
Voice anaysis
patient voice that is recorded during the study will be anylaysis with specific algorithms
Time frame: 1-2 years
Plan to share: No
No publications or documents are linked to this record.
Ran from Apr 2020 to primary completion in May 2021, 12 months.
Of 245 observational studies under Coronavirus Infections, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's 12 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cordio Medical